| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |